Physicians' use and perceptions of genetic testing for rare diseases in China: a nationwide cross-sectional study

• Published in: Orphanet journal of rare diseases Vol. 18; no. 1; p. 240
• Main Authors: Liu, Weida, Liu, Peng, Guo, Dan, Jin, Ye, Zhao, Kun, Zheng, Jiayin, Li, Kexin, Li, Linkang, Zhang, Shuyang
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 10-08-2023; BioMed Central; BMC
• Subjects: Accessibility; Collaboration; Cross-sectional studies; Departments; Diagnosis; Disease management; Epidemiology; Genetic disorders; Genetic screening; Genetic testing; Health aspects; Medical diagnosis; Medical personnel; Medical research; Medical tests; Medical treatment; Medicine, Experimental; Pediatrics; Physicians; Questionnaires; Rare diseases; Resource utilization; Surveys; Utilization; China; Rare diseases; Utilization; Genetic testing; Accessibility
• ISSN: 1750-1172; 1750-1172
• DOI: 10.1186/s13023-023-02847-7

Genetic testing can facilitate the diagnosis and subsequent therapeutic management of rare diseases. However, there is a lack of data on the use of genetic testing for rare diseases. This study aims to describe the utilization rate and troubles encountered by clinicians in treating rare diseases with genetic testing.
A cross-sectional electronic questionnaire survey was conducted between June and October 2022 among the medical staff from the hospitals covering all provinces, municipalities, and autonomous regions of China. The survey on genetic testing focused on whether genetic testing was used in the diagnosis and treatment of rare diseases, the specific methods of genetic testing, and the problems encountered when using genetic testing.
A total of 20,132 physicians who had treated rare diseases were included, of whom 35.5% were from the central region, 36.7% were from the eastern region, and 27.8% were from the western region. The total utilization rate of genetic testing for rare diseases was 76.0% (95%CI: 75.4-76.6). The use of genetic testing was highest in the Eastern region (79.2% [95% CI: 78.3-80.1]), followed by the Central (75.9% [95% CI: 74.9-76.9]) and Western regions (71.9% [95% CI: 70.7-73.1]). More than 90% (94.1% [95%CI: 93.4-94.8]) of pediatricians had used genetic testing to treat rare diseases, with surgeons having the lowest use of genetic testing (58.3% [95% CI: 56.6-60.0]). Physicians' departments and education levels affect the use of genetic testing. Most physicians have used a variety of genetic tests in the management of rare diseases, the most popular methods were "Whole-exome sequencing (Proband)" and "Whole-exome sequencing (families of three or more)". Doctors have encountered many problems with the use of genetic testing in the diagnosis and treatment of rare diseases, among which the high price was the main concern of medical workers.
Three-quarters of physicians used genetic testing in rare disease practice, and there were regional differences in the use of genetic testing. Recognition of the utilization of genetic testing can help identify patterns of resource utilization in different regions and provide a more comprehensive picture of the epidemiology of rare diseases in jurisdictions.